Knoll
This article was originally published in The Tan Sheet
Executive Summary
Files ANDA suitability petition March 22 for "solubilized" ibuprofen - a.k.a. Whitehall's Advil Liqui-Gels. Knoll's proposed branded ibuprofen product would differ from the reference drug in that it would be in tablet form, processed from a solid, "extruded" form of the liquid ibuprofen solution used in the currently marketed soft gel product. The firm's petition includes data showing what Knoll describes as "substantial equivalence" between the proposed ibuprofen product, Advil Liqui-Gels and two other ibuprofen products. The new tablet is said to have faster absorption than standard ibuprofen tablets, similar to the liquid gel product. Knoll has published for third-party review a variety of trademarks for pharmaceuticals and dietary supplements manufactured using "melt extrusion" technology
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning